Insider Buying: CVS Group (LON:CVSG) Insider Purchases £19,140 in Stock

CVS Group plc (LON:CVSG) insider David Wilton purchased 1,500 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were acquired at an average cost of GBX 1,276 per share, with a total value of £19,140.

CVS Group Price Performance

Shares of CVSG opened at GBX 1,300 on Friday. The stock has a market cap of £889.76 million, a PE ratio of 18.87, a price-to-earnings-growth ratio of 1.77 and a beta of 1.06. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. CVS Group plc has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,648. The firm’s 50-day simple moving average is GBX 1,233.99 and its two-hundred day simple moving average is GBX 1,242.36.

CVS Group declared that its board has initiated a stock buyback plan on Tuesday, May 26th that allows the company to buyback 0 shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CVSG shares. Berenberg Bank restated a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a research note on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,700 price objective on shares of CVS Group in a research note on Monday, July 27th. Finally, Jefferies Financial Group boosted their target price on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a “hold” rating in a report on Friday, July 31st. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of GBX 1,720.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.